Corrine Welt is an Endocrinology/Metabolic physician affiliated with University of Utah. OpenAlex indexes 166 publications with 12,504 citations (h-index 55); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Metformin Treatment in Polycystic Ovary Syndrome (PCOS)
Sponsor: Massachusetts General Hospital
- The Safety and Efficacy of Recombinant Human Prolactin
Sponsor: Massachusetts General Hospital
- Recombinant Human Prolactin for Lactation Induction
Sponsor: Massachusetts General Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
55.1%Biguanide (metformin)28.6%Metformin Hcl Er100%Part D<11 patientsalpha-Glucosidase Inhibitor26.5%Acarbose100%Part D<11 patientsHormonal (systemic)
44.9%l-Thyroxine44.9%Levothyroxine Sodium100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Comorbid Disease in Women with Primary Ovarian Insufficiency
Utah State Higher Education System--University of Utah
FY2026$558,419R01HD099487 - Comorbid Disease in Women with Primary Ovarian Insufficiency
Utah State Higher Education System--University of Utah
FY2025$558,419R01HD099487 - Primary Ovarian Insufficiency: Etiology and Comorbid Disease
University of Utah
FY2023$317,581R01HD099487
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
James Fang
University of Utah
Wallace Akerley, MD
University of Utah
Randall Burt, MD
University of Utah
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”